Catherine Novack
Stock Analyst at Jones Trading
(1.23)
# 3,721
Out of 5,090 analysts
22
Total ratings
22.22%
Success rate
-3.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Downgrades: Hold | n/a | $6.97 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $12.40 | +166.24% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $20.75 | +44.58% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $25.51 | +13.70% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.91 | +556.81% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.67 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $93.90 | -52.07% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.15 | +412.82% | 1 | Feb 12, 2025 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.88 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $7.56 | +111.64% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.68 | +280.95% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $1.78 | +630.34% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $9.59 | +4.23% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $4.65 | +373.12% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.24 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.85 | +18,781.28% | 1 | Jul 21, 2023 |
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $6.97
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $12.40
Upside: +166.24%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $20.75
Upside: +44.58%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $25.51
Upside: +13.70%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.91
Upside: +556.81%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.67
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $93.90
Upside: -52.07%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.15
Upside: +412.82%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.88
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $7.56
Upside: +111.64%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.68
Upside: +280.95%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $1.78
Upside: +630.34%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $9.59
Upside: +4.23%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $4.65
Upside: +373.12%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.24
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.85
Upside: +18,781.28%